Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • A low omega-6, omega-3 rich diet and fish oil may slow prostate cancer growth
    16 December 2024

    A low omega-6, omega-3 rich diet and fish oil may slow prostate cancer growth : study finds

    A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may help reduce cancer cell growth in patients undergoing active surveillance, a treatment approach that involves regular monitoring of the cancer without immediate intervention.

  • 13 December 2024
    Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial
    Updated results from the OlympiA Phase III trial showed AstraZeneca and MSDs Lynparza olaparib demonstrated sustained, clinically meaningful improvements in overall survival , invasive disease-free survival IDFS and distant disease-free survival DDFS at six years for patients with germline BRCA-mutated gBRCAm HER2-negative high-risk early breast cancer.
  • 13 December 2024
    IBRANCE® in combination with Standard-of-Care therapies extends survival by over 15 months
    Pfizer Inc. and Alliance Foundation Trials, LLC announced results from the Phase 3 PATINA trial demonstrating that the addition of IBRANCE palbociclib to current standard-of-care first-line maintenance therapy following induction chemotherapy resulted in statistically significant and clinically meaningful improvement in progression-free survival by investigator assessment in patients with hormone receptor-positive
  • 13 December 2024
    Antidepressants may act in gut to reduce depression and anxiety

    Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.

  • 13 December 2024
    A new class of antivirals could help prevent future pandemics
    The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that at some point, Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections—work that may have even broader implications.
  • 12 December 2024
    Cipla receives approval for distribution and marketing of inhaled insulin in India
    Cipla Limited announced that it has obtained regulatory approval from Central Drugs Standard Control Organisation for the exclusive distribution and marketing of Afrezza insulin human Inhalation Powder in India. Afrezza, a product created and manufactured by MannKind Corporation
  • 12 December 2024
    Identifying a proliferating repairman for tissue in damaged lungs

    Veins in the lungs, or pulmonary veins, play a critical role not only in lung functioning but also in maintaining sufficient oxygen in tissue throughout the body. When a person sustains pulmonary injury from an illness like influenza or COVID, repair of blood vessels and the creation of new ones is vital to meet oxygen demands; however, research in these areas remains underexplored.

  • 12 December 2024
    Updated Hep B Vaccine More Effective for People with HIV

    A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.

  • 12 December 2024
    Stanford scientists transform ubiquitous skin bacterium into a topical vaccine

    Imagine a world in which a vaccine is a cream you rub onto your skin instead of a needle a health care worker pushes into your one of your muscles. Even better, it’s entirely pain-free and not followed by fever, swelling, redness or a sore arm. No standing in a long line to get it. Plus, it’s cheap.

  • 12 December 2024
    Academically Announces Outstanding KAPS 2024 Results and OPRA Exam Transition

    Academically, a pioneering healthcare EdTech company, proudly shares the exciting news of its students' exceptional performance in the final KAPS (Knowledge Assessment of Pharmaceutical Sciences) exam before transitioning to the OPRA (Overseas Pharmacists Readiness Assessment). Held on 25th November 2024, this final edition of the exam saw Academically students achieving a remarkable success rate of 90.51%.

Subscribe to Pharma News